Back
Mersana Therapeutics 10K Form
Buy
51
MRSN
Mersana Therapeutics
Last Price:
$0.42
Seasonality Move:
11.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-07 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2020-05-08 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2020-02-28 | 10K | MRSN/Mersana Therapeutics Annual |
| 2019-11-06 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2019-08-08 | 10Q | MRSN/Mersana Therapeutics Quarterly |
| 2019-05-09 | 10Q | MRSN/Mersana Therapeutics Quarterly |
Receive MRSN News And Ratings
See the #1 stock for the next 7 days that we like better than MRSN
MRSN Financial Statistics
Sales & Book Value
| Annual Sales: | $40.5M |
|---|---|
| Cash Flow: | $-19.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.08 |
| Price / Book: | 57.95 |
Profitability
| EPS (TTM): | -0.56000 |
|---|---|
| Net Income (TTM): | $-69.2M |
| Gross Margin: | -- |
| Return on Equity: | -533.43% |
| Return on Assets: | -37.7% |
Mersana Therapeutics Earnings Forecast
Key Mersana Therapeutics Financial Ratios
-
The Research & Development expenses have been 180.31% of Revenue.
-
The Net Earning history of MRSN is -170.86% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 6 years.
Mersana Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRSN |
| CUSIP: | 59045L |
| Website: | mersana.com |
Debt
| Debt-to-Equity Ratio: | -2.47 |
|---|---|
| Current Ratio: | 2.19 |
| Quick Ratio: | 2.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MRSN Technical Analysis vs Fundamental Analysis
Buy
51
Mersana Therapeutics (MRSN)
is a Buy
Is Mersana Therapeutics a Buy or a Sell?
-
Mersana Therapeutics stock is rated a BuyThe current Mersana Therapeutics [MRSN] share price is $0.43. The Score for MRSN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.